ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
180 hedge funds and large institutions have $2.55B invested in Intra-Cellular Therapies Inc. in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 77 increasing their positions, 49 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
6% less capital invested
Capital invested by funds: $2.72B → $2.55B (-$173M)
27% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 26
Holders
180
Holding in Top 10
3
Calls
$31M
Puts
$7.67M
Top Buyers
| 1 | +$60.3M | |
| 2 | +$21.1M | |
| 3 | +$14.5M | |
| 4 |
GPSPJS
General Pension Society PZU Joint Stock
Warsaw,
Poland
|
+$9.96M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$9.45M |
Top Sellers
| 1 | -$38.8M | |
| 2 | -$17.7M | |
| 3 | -$14.4M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.2M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$11.1M |